Top-notch biotech stocks TG Therapeutics and Twist Bioscience took a tumble Monday on mixed second-quarter reports.
Why This Top-Notch Trio Of Biotech Stocks Just Took A Tumble
Licensing
09:36 AM ET 08/03/2026
Top-notch biotech stocks TG Therapeutics (TGTX) and Twist Bioscience (TWST) took a tumble Monday on mixed second-quarter reports that both featured earnings misses. For TG Therapeutics, the miss was due to analysts underestimating operating expenses, Evercore ISI analyst Michael DiFiore said in a report. The company earned 5 cents a share, well below the Street's forecast for a 31-cent gain.…
Twist Bioscience (NASDAQ: TWST) stock is up on strong Q3 results and raised guidance. AI drug discovery and NGS businesses show…
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TG Therapeutics (TGTX), Apogee…
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock
The drugmaker came up with a mixed second-quarter report and outlook cut.
Medical research stocks took a bath Thursday, helped by BillionToOne's report, featuring a beat but no guidance hike.
Warning: RSI is above 70 for 3 overbought stocks in healthcare. Progyny, 10X Genomics, and Privia Health have high RSI values and…
Twist Bioscience Sees AI Drug Discovery Pipeline Expand - Twist Bioscience (NASDAQ:TWST)
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock
Top 3 Health Care Stocks You'll Regret Missing This Quarter - PTC Therapeutics (NASDAQ:PTCT), Legend Biot
Context Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move - Context Therap
Health Care Down on Rotation Out of Defense - Health Care Roundup
